This inventor holds 31 USPTO granted patents and 1 published patent application and 5 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Eli Lilly and Company, G.d. Searle & Company, Pharmacia Corporation. Active years: 1997-2017.
Location History:
- Indiannapolis, IN (US) (2004)
- Indianapolis, IN (US) (1997 - 2017)
Company Filing History:
20 out of 4,509 
5 out of 1,323 
5 out of 220 
Years Active: 1997-2017
Areas of Expertise:
Title: Bryan Hurst Norman: A Pioneer in Autotaxin Inhibitors
Introduction
Bryan Hurst Norman, based in Indianapolis, IN, is a prominent inventor with an impressive portfolio, holding a total of 31 patents. His contributions to the field of pharmaceuticals, particularly in the development of autotaxin inhibitors, are notable and have significant implications for the treatment of pain associated with conditions such as osteoarthritis.
Latest Patents
Among his latest innovations, Norman has developed compounds like dihydropyrido pyrimidine compounds, which serve as autotaxin inhibitors. These compounds are beneficial in alleviating pain linked to osteoarthritis. Another significant patent involves imidazo pyridine compounds, which also function as autotaxin inhibitors. These breakthroughs continue to push the boundaries of medical science and improve patient outcomes.
Career Highlights
Throughout his career, Bryan Hurst Norman has made substantial contributions to leading companies in the pharmaceutical sector. He has worked with Eli Lilly and Company, where he likely enhanced his expertise in drug development and research. Additionally, his tenure at G.D. Searle & Company further solidified his reputation within the industry, allowing him to focus on innovative therapeutic strategies.
Collaborations
Norman has collaborated with esteemed colleagues, including James A. Sikorski and Balekudru Devadas. These partnerships have undoubtedly enriched his research endeavors and led to impactful advancements in the field.
Conclusion
Bryan Hurst Norman's innovative spirit and dedication to research exemplify the essence of a successful inventor. His work in autotaxin inhibitors not only marks significant progress in pharmaceuticals but also showcases the importance of collaboration in driving scientific advancements. As he continues to push the boundaries of innovation, Norman remains a key figure in the landscape of modern medicine.